Merit Medical Systems | MMSI - Loan Capital


Merit Medical Systems reported $734.04M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
3M USD 10.93B 922M Dec/2025
Abbott USD 9.9B 1.7B Dec/2025
AngioDynamics USD 5.9M 5.9M Feb/2025
Anika Therapeutics USD 0 0 Mar/2025
AtriCure USD 61.86M 0 Dec/2025
Baxter International USD 9.47B 726M Dec/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Boston Scientific USD 10.99B 12M Sep/2025
Cooper Companies USD 2.46B 26.1M Sep/2025
Dexcom USD 1.24B 53.6M Dec/2025
Edwards Lifesciences USD 598.2M 200K Sep/2025
Globus Medical USD 427K 254K Sep/2025
Haemonetics USD 919.99M 406K Dec/2025
Hologic USD 2.5B 2.1M Dec/2025
ICU Medical USD 1.27B 48.01M Dec/2025
Insulet USD 930.8M 4.1M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
J&J USD 39.44B 30M Dec/2025
Medtronic USD 27.62B 1.45B Sep/2025
Merit Medical Systems USD 734.04M 1.12M Dec/2025
Olympus JPY 159.64B 74.23B Dec/2025
Pfizer USD 57.41B 93M Sep/2025
STAAR Surgical USD 42K 42K Dec/2023
Stryker USD 14.86B 14M Dec/2025
Surmodics USD 29.55M 30K Sep/2024
Tandem Diabetes Care USD 310.04M 446K Dec/2025
Teleflex USD 2.54B 30.06M Dec/2025
Terumo JPY 99.9B 12M Dec/2025
Zimmer Biomet Holdings USD 6.93B 580.6M Dec/2025